hmmm wrote: » A beneficial side-effect is that it may also generate a bit of a mania for getting the vaccination. You'll feel you are missing out when your friends are all repeatedly refreshing the vaccination website at 9am as if it was the queue for PS5s.
PhoenixParker wrote: » The reality is 80% of the adult population will be done in the next 12 weeks, at a rate of over 250k most weeks. Segmenting off 100k teachers here and 50k adults in overcrowded places there makes little sense considering the hassle involved. By the time you'd work out a plan to visit every school twice and who precisely in each school qualifies and then adjudicate all of the edge cases. . . you'd be 6 weeks getting them all done anyway. (Look at the nursing homes which was fairly tightly planned). MCVs and GPS, whack it out by age and blast through it.
is_that_so wrote: » IMO it'll be surprising to see it up and running by the end of May at the current rates.
celt262 wrote: » Its there already and has been used by the HSE as a poster here kindly informed me earlier today.
is_that_so wrote: » I don't think they will. IMO they do have a plan, models etc but it's utterly contingent on the likes of AZ not ringing up on a Sunday to say they are not delivering this week. As has been said more than once they really don't trust AZ promises now and at 20% of our plans that could throw models sideways very fast.
is_that_so wrote: » Is there a link to it?
BigMo1 wrote: » AZ can't seem to shake these clot reports.https://www.irishtimes.com/news/world/europe/fresh-blow-to-astrazeneca-vaccine-as-germany-reassesses-use-1.4524020
Cork2021 wrote: » Looks like J&J will deliver what they’re supposed to deliver from mid April! This is well help move us forward quicker. Also will this be the winter shot???https://amp.cnn.com/cnn/world/live-news/coronavirus-pandemic-vaccine-updates-03-29-21/index.html?__twitter_impression=true
stephenjmcd wrote: » That CNN article is doing the rounds and its quite misleading, have also seen it referenced on twitter suggestions of the full order being delivered in Q2. It's still 600k in Q2 from J&J beginning April and amounts getting larger as we through May & June.
Stark wrote: » That's really worrying for our vaccination rollout program. Wonder are we better to switch our over-70s over to AstraZeneca and start giving Pfizer/Moderna to young people instead. If we get all our over-70s done and it turns out we can't use any more AstraZeneca, we're screwed. Interestingly, Sputnik V and Johnson & Johnson are both very similar (viral vector vaccines). I imagine you'd expect to see similar issues there.
eagle eye wrote: » How many people have taken AZ, how many blood clots, is it over 11 million with blood clots? At this stage I think I'll avoid AZ. I'm sure I can manage to be unable to make it until it's some other vaccine they are offering. There's just too much of this stuff going on.
josip wrote: » Looks like AZ is reasonably safe for men. Making it men only would allow us to continue according to plan.
Cork2021 wrote: » Over Caution is going to be the downfall of some countries vaccination programmes!
Cork2021 wrote: » You won’t be given a choice but sure don’t get vaccinated and miss out when we’re all swanning off to the pub or a gig with our QR code to say we’ve been vaccinated
VG31 wrote: » A possible issue I have with getting the AZ vaccine is the 12 week gap between doses. If for example, I get the first dose of AZ in mid June (optimistic). The general concensus for fully vaccinated is two weeks after the second dose. That means it could be the end of September or even October before I would actually be regarded as vaccinated. In comparison getting Pfizer or Moderna in mid June would have me fully vaccinated by the end of July. If they changed it so people who get AZ are regarded as vaccinated with the first dose I wouldn't have an issue, although it still might cause issues for foreign travel.
lbj666 wrote: » There's enough evidence to suggest 1 dose AZ will significantly reduce the chance of severe illness, take what your given.